Patents by Inventor Anthony Barrington Kay

Anthony Barrington Kay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160120965
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides
    Type: Application
    Filed: September 11, 2015
    Publication date: May 5, 2016
    Inventors: RODERICK PETER HAFNER, MARK LARCHE, ANTHONY BARRINGTON KAY
  • Patent number: 9168295
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: October 27, 2015
    Assignee: Circassia Limited
    Inventors: Roderick Peter Hafner, Mark Larche, Anthony Barrington Kay
  • Publication number: 20140050750
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides
    Type: Application
    Filed: August 22, 2013
    Publication date: February 20, 2014
    Applicant: CIRCASSIA LIMITED
    Inventors: RODERICK PETER HAFNER, MARK LARCHE, ANTHONY BARRINGTON KAY
  • Patent number: 8551492
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: October 8, 2013
    Assignee: Circassia Limited
    Inventors: Roderick Peter Hafner, Mark Larche, Anthony Barrington Kay
  • Publication number: 20100239599
    Abstract: The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides.
    Type: Application
    Filed: May 30, 2008
    Publication date: September 23, 2010
    Applicant: CIRCASSIA LIMITED
    Inventors: Roderick Peter Hafner, Mark Larche, Anthony Barrington Kay
  • Patent number: 6737406
    Abstract: The present invention relates to immunologically cryptic peptides; methods for their identification in individuals and populations and their use in diagnosis and therapy of pathological conditions such as asthma and allergy, and their use in screening for therapeutic activity. Such cryptic peptides are identified by a method which includes the steps of: 1) exposing T cells with the peptide in a primary challenge; 2) measuring the reactivity of T cells with the peptide in the primary challenge of step 1); 3) exposing pre-challenged T cells with the peptide in a secondary challenge, wherein the pre-challenged T cells are obtainable by exposign the T cells to the protein; and measuring the reactivity of the pre-challenged T cells with the peptide in the secondary challenge of step 3), and the peptide is a cryptic peptide if T-cell reactivity is observable in the secondary challenge but not in the primary challenge.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: May 18, 2004
    Assignee: Circassia, Ltd.
    Inventors: Anthony Barrington Kay, Mark Larche